Cómo proceder ante personal sanitario alérgico a la vacuna de ARNm contra el COVID-19 / How to deal with healthcare workers allergic to COVID-19 mRNA vaccine
Rev. Asoc. Esp. Espec. Med. Trab
; 31(3): 295-299, sep. 2022. tab
Artigo
em Espanhol
| IBECS
| ID: ibc-213162
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
RESUMEN
Notifican al Servicio de Prevención y Riesgos Laborales el caso de una enfermera de 37 años que refiere rinorrea acuosa y prurito generalizado 10-15 minutos tras la administración de la primera dosis vacunal generada por BioNTech/Pfizer. Presenta eritema facial, habón maxilar y constantes normales. ¿Cómo debe actuar el Servicio de Prevención y Riesgos Laborales (SPRL) frente a una trabajadora sanitaria que sufre una reacción alérgica a la vacuna de ARNm contra el COVID-19?Este caso clínico llama la atención sobre medidas preventivas habituales como la vacunación pero también sobre otras como la colaboración entre diferentes servicios hospitalarios, el manejo y diagnóstico por Alergología, seguimiento del Servicio de Prevención y notificación de efectos vacunales adversos por Farmacología Clínica.La coordinación entre estos servicios resulta fundamental para el correcto manejo de trabajadores afectados por reacciones adversas frente a la primera dosis vacunal contra el COVID-19 pudiendo quedar vacunados y protegidos. (AU)
ABSTRACT
The Occupational Risk and Prevention Service is notified the case of a 37-year-old nurse who reported watery rhinorrhea and generalized itching 10-15 minutes after first dose of the vaccine produced by BioNTech/Pfizers administration. She presents facial erythema, maxillary wheal and normal constants. How should the Occupational Risk and Prevention Service should deal with a health worker who suffers an allergic reaction to the mRNA vaccine against COVID-19?This clinical case draws attention to common preventive measures such as vaccination, but also to others such as collaboration between different hospital services, management and diagnosis by Allergology, follow-up by the Occupational Risk and Prevention Service and notification of adverse vaccine effects by Clinical Pharmacology.Coordination between these services is essential for the correct management of workers affected by adverse reactions to the first vaccine dose against COVID-19, being the workers able to be vaccinated and protected. (AU)
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Vacinação em Massa
/
Pessoal de Saúde
/
Infecções por Coronavirus
/
Pandemias
Limite:
Adulto
/
Feminino
/
Humanos
Idioma:
Espanhol
Revista:
Rev. Asoc. Esp. Espec. Med. Trab
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Hospital Universitario Puerta de Hierro/España